 |
|
Current Position:
 | Attending Physician, Mount Sinai Comprehensive Cancer Center and Mount Sinai Medical Center. Miami Beach, Florida |
Academic appointments:
| | Assistant Professor of Medicine University of Miami and Nova Southeastern University |
Education:
| | M.D., Pontificia Universidad Javeriana (Bogota, Colombia)
1988 - 1994 |
Post Graduate Education:
| | Internship and Residency in Medicine
Maimonides Medical Center
Brooklyn, New York
1997 - 2000 |
| | Fellowship in Hematology - Oncology
University of Maryland, Greenebaum Cancer Center
Baltimore, Maryland
2000 - 2003 |
Certifications
| | Educational Commission for Foreign Medical Graduates
1996 |
| | Diplomate, American Board of Internal Medicine
2000 |
| | Diplomate, American Board of Medical Oncology
2003 |
| | Diplomate, American Board of Hematology
2003 |
Medical Licensures
| | State of Maryland (D0058136)
2001 |
| | State of Florida (ME87084)
2003 |
Employment History
| | Salick Health Care, Inc.
Mount Sinai Comprehensive Cancer Center
2003 |
| | Director of Health Services and Staff Physician
Foundation Children of the Andes (Bogota, Colombia)
1994 - 1995 |
| | Emergency Department Staff Physician
Clinica del Country (Bogota, Colombia)
1996 - 1997 |
Professional Memberships
| | Member, American College of Physicians
1997 |
| | Associate Member, American Society of hematology
2001 |
| | Associate Member, American Society of Clinical Oncology
2001 |
| | Associate Member, American Association for Cancer Research
2002 |
Honors and Awards
| | Attending of the year
Mount Sinai Medical Center
2004 |
| | National Oncology Fellows' Forum
Phase II Trial of Modified AIO Regimen, CPT-11 High Dose Leucovorin and 24-hour infusion of 5-FU in patients with Metastatic Colorectal Cancer.
2002 |
| | Outstanding Second Year Resident
Maimonides Medical Center
1999 |
| | Shofar Award
Awarded for Meritorious work for the youth of the Colombian Jewish Community.
1997 |
| | International Medical Student Exchange Program with Brown University
Awarded to two students out of eighty every semester in the Pontificia Universidad Javeriana, School of Medicine
1991 |
Institutional Service
| | Developed Protocols for Primary Care Delivery in the Emergency Department of Rural Hospitals in Colombia. June 1994 Hospital San Rafael, Guateque, Colombia. |
| | Coordinator of the Jewish Community Search and Rescue Group
Colombian Red Cross, Search and Rescue Group
1994 - 1997 |
| | Chief Fellow Hematology - Oncology
University of Maryland Greenebaum Cancer Center
2002- 2003 |
Teaching Responsibilities
| | Assistant Instructor of Physiology
Class size: 60, 5 students/groups
Pontificia Universidad Javeriana (Bogota, Colombia)
1989 - 1992 |
| | Instructor of Medical Physiology Postgraduate Programs
Class size: 10 Students
Colombian Dental Association (Bogota, Colombia)
1995 - 1996 |
| | Preceptor, Small Group Session in Physical Diagnosis
4 Students/Group
University of Maryland, School of Medicine
2001 - 2003 |
| | Resident Chalk-Talks
Residents and Medical Students rotating in the Cancer Center
University of Maryland, Department of Medicine
2001 - 2003 |
| | Assistant Clinical Instructor
University of Maryland, School of Medicine
2000 - 2003 |
| | Attending Physician
Mount Sinai Medical Center.
2003 - present |
Grant Support
| | Co-Principal Investigator
Principal Investigator: David A. Van Echo
"Phase II Trial of Combination Chemotherapy with Gemcitabine, Docetaxel and Capecitabine for Treatment of Locally Advanced, Metastatic or Recurrent Head and Neck Cancers"
Aventis Pharmaceuticals (Investigator Initiated)
2002 - present |
| | Co-Principal Investigator
Principal Investigator: Yehuda Z. Patt
"Phase II trial of Capecitabine and Pegylated interferon for patients with non-resectable Hepatocellular carcinoma"
Hoffman La-Roche pharmaceuticals (Investigator Initiated)
2002 - present |
Unpublished Research
| | Incidence of Abdominal Pain in the Pediatric Population, Retrospective Study. 1992, Dept of Pediatrics, Clinica de Colsubsidio, Bogota, Colombia. |
Ongoing Research
| | A Phase I study of Paclitaxel, Xeloda and Radiation Therapy for abdominal maliganacies excluding colorectal. Co-investigator |
| | Phase I study of CPT-11, Xeloda and Radiation Therapy for Colorectal Cancer. Co-investigator |
| | A Phase II Study of Gemcitabine, Taxotere and Xeloda Combination Chemotherapy in Patients with Locally Advanced, Metastatic or Recurrent Head and Neck Cancer. Co-investigator. |
| | Phase II study of a Biochemically Synergistic Regimen for Advanced Pancreatic Cancer: Gemcitabine-Docetaxel-Capecitabine (GTX). Co-investigator. |
| | Phase II study of Modified Gemcitabine-Docetaxel-Capecitabine (Modified GTX) as second line therapy for Advanced Pancreatic Cancer. Co-investigator. |
| | A Phase I Study of metronomic-time sequential chemotherapy with Docetaxel, Gemcitabine, Capecitabine and Radiation Therapy for Abdominal Malignancies Excluding Colorectal and Genitourinary. Co-investigator. |
| | "Phase II trial of Capecitabine and Pegylated interferon for patients with non-resectable Hepatocellular carcinoma" Co-Investigator. |
Publications
Abstracts
| | *GTX. Gemcitabine, Taxotere, Xeloda combination chemotherapy in advanced pancreatic adenocarcinoma. David Van Echo, Mike Cusnir, Richard Burdick, Richard Zak. European Society of Medical Oncology 2004. |
| | *Phlegmasia cerulea dolens and acute ischemic venous thrombosis in patients with colon cancer. David Varnagy, Jeffrey Hertz, Harry Sendzischew, Mike Cusnir, Enrique Davila. Florida vascular society 2004. |
| | *Biochemically synergistic chemotherapy for advanced pancreatic cancer (PC). Robert L Fine, William Sherman, John Chabot, Stephen Schreibman, Michael Williams, Michael Cusnir, David Van Echo. Proc Am Soc Clin Oncol 2002. A575 |
| | Phase II trial of modified AIO regimen, CPT-11 (C), high dose leucovorin (LV) and 24 hour infusion 5-FU (FU) in patients with metastatic colorectal cancer (MCRC). Mike Cusnir, David A Van Echo, Gary Cohen, William Waterfield, David H Smith, Nancy Kennedy. Proc Am Soc Clin Oncol 2002. A2241 |
| | *Capecitabine combined with conformal radiation therapy in gastrointestinal malignancies: Phase I studies at university of Maryland.Van Echo D, Cusnir M, Speca J, Duckham E, Kennedy A. Proc of 12th International Congress of Anti-Cancer Treatment. Feb 2002 |
| | *Phase II Trial of Modified AIO Regimen, CPT-11 High Dose Leucovorin and 24-hour infusion of 5-FU in patients with Metastatic Colorectal Cancer. Cusnir M, Van Echo D, Gary Cohen, William Waterfield, David H Smith, Nancy Kennedy. National Oncology Fellows' Forum 2002. |
* Poster or Oral Presentation.
Journal Articles (Peer Reviewed)
| | Cusnir M, Mendoza R, Rosales L, Ortega A. Immunologic Interference in Viral Vaccines: The Influence of Salmonella Infection in the Immunity of Measles Vaccine. Revista Medica Estudiantil, Year 2, Num 4, Nov 1990. Pag 18 - 21 |
| | Cusnir M, Patt YZ. Novel systhemic therapies from the treatment of Hepatocellular carcinoma. The Cancer Journal 10(2), March 2004 pag 97-104 |
| | Cunningham S.C., Cusnir M, Burdick R, Van Echo D.A., Moesinger R. Neoajuvant chemoradiation to convert loacallt advanced pancreatic body adenocarcinoma to respectable disease. Clinical advances in Hematology and Oncology, 1(12). Dec 2003. |
| | Phase II Trial of modified AIO regimen, CPT-11(C), high dose Leucovorin (LV) and 24 hour infusion 5-Fu (FU) in patients with Metastatic Colorectal Cancer (MCRC). Manuscript submitted. |
| | Phase I trial of combination chemotherapy with Docetaxel, Cisplatin and Capecitabine in solid tumors. Manuscript submitted. |
| | Phlegmasia cerulea dolens and acute ischemic venous thrombosis in patients with colon cancer. Case report and review of literature. Manuscript submitted |
Major Invited Speeches or Talks
| | Residents Noon Conference
Department of Internal Medicine, Maryland General Hospital.
2002 |
| | Hematology - Oncology Grand Rounds
Greenebaum Cancer Center, University of Maryland.
2003 |
| | Mount Sinai Medical Center, Grand rounds.
2003 |
| | American Association of Physician Assistants in Oncology,
Annual meeting.
2004 |
|
